Navigation Links
Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)
Date:6/23/2011

ANN ARBOR, Mich., June 23, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical trial of patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease. Preparations are underway to evaluate the safety and efficacy of the Company's proprietary drug candidates, AEN-100, a gastroretentive, sustained-release zinc-based tablet, and AEN-200, a copper tablet, in a multi-center, double-blind, placebo-controlled clinical trial in ALS patients intended to be conducted under an Investigational New Drug (IND) application. Adeona will provide the study medications and fund the clinical trial, which will be conducted by the neurology team at the PNA Center for Neurological Research in collaboration with The Institute for EthnoMedicine.

Planned Phase IIb Clinical Trial in ALS Patients Evaluating Adeona's Zinc-Based Therapy

Preparation of the planned Phase IIb clinical protocol is currently ongoing for submission to the Food & Drug Administration (FDA) as an addition to a current IND application. Efforts are also underway for the manufacturing of clinical trial medications and protocol review by an Institutional Review Board. The multi-center trial is intended to take place at up to six major ALS centers in the United States. It is anticipated that the trial will enroll 60 ALS patients, who will continue on RILUTEK® (riluzole) as the standard of care treatment. The patients will be randomized into treatment and matching placebo groups and will receive clinical trial medications for 12 months with periodic monitoring. The treatment group will receive Adeona's proprietary drug candidates – AEN-100, a zinc-based tab
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Adeona Announces Second Quarter 2010 Profitability and Achievements
4. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona to Hold Annual Shareholder Meeting
7. Adeona Announces Third Quarter 2010 Financial Results and Achievements
8. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
9. Adeona to Present at OneMedForum San Francisco 2011 Conference
10. Adeona to Host Investor Day on Zinc Deficiency in Alzheimers Disease
11. Adeona to Raise $4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with the growth ... a later starter. In 2012, the size of ... with the proportion worldwide soaring to 16.3%. It is projected ... continue its growth rate by around 20% in the upcoming ... roughly RMB25 billion. An integrated membrane industrial system ...
(Date:12/17/2014)... STUTTGART , Alemania, December 17, 2014 ... del año anterior, con un alto nivel de gasto ... pasado año fiscal 2013/14 (finalizado el 30 de septiembre ... por ciento a 4.287 millones de euros (año anterior: ... de la moneda desfavorables. Las ganancias (EBIT) crecieron un ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
... , Jan. 17 In the last decade, ... with a staggering 4000% increase in the diagnosis of bipolar ... prescriptions for antidepressants in 2008. Pharmaceutical companies spend billions of ... there a connection? And when a patient experiences harm from ...
... , LOS ANGELES , Jan. 16 ... Tuesday, 4 Survival To Go , an emergency preparedness company based in ... Mourning to help provide aid to the impoverished nation via the newly ... of February, 4 Survival To Go will donate 20% of online ...
Cached Medicine Technology:Pharmaceutical Direct to Consumer Advertising on The American Law Journal 2Pharmaceutical Direct to Consumer Advertising on The American Law Journal 3Help the Haitian Community and Prepare for an Unexpected Disaster 2Help the Haitian Community and Prepare for an Unexpected Disaster 3Help the Haitian Community and Prepare for an Unexpected Disaster 4
(Date:12/21/2014)... 2014 Over the past 39 years, ... hundreds of emergency departments across the nation, from quality ... been translated into an innovative suite of tools, systems, ... and enhance the patient experience. , NES Health, ... and management services for hospitals, announced the development and ...
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation ... and Whittier offices. The Hope for the Holidays Toy Drive ... and their families during the holiday season. This year, the ... children between both offices. This event continues to be successful ... service team, store managers and assistant managers came out and ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Weddingshe.com has ... and launched a site-wide promotion of special occasion dresses ... a popular supplier of special occasion dresses for global ... offered with big discounts, up to 80% off. Among ... Sweetheart Sequins Short Sweet 16 Dress) is very popular. ...
(Date:12/20/2014)... News) -- The holidays can be anything but joyous ... trees, scented candles and other allergy triggers. "The ... have been packed away in dank basements or dusty ... patients," Dr. Rachna Shah, an affiliate faculty member at ... Loyola news release. Shah, who is also an ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Atore, Inc, ... company just launched first birthday focused portal on December ... BIRTHDAY MESSAGE” launched in both US and Japan. , ... MESSAGE : http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE ... birthday around the world. , Features, Choose from thousands ...
Breaking Medicine News(10 mins):Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:Holiday Trimmings Can Trigger Allergies 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... shows promise for reducing bacterial growth , , FRIDAY, ... may help fight strep infections have been identified ... more common among infection-causing bacteria, researchers have warned. ... involves new antimicrobial agents that suppress bacteria virulence ...
... twins, Tracy and Lanny Barnes are ranked among the top competitors in ... the gold at the 2010 Winter Games to be held in Vancouver, ... made with hot pepper extract for helping them get the most out ... ...
... Lombardi Comprehensive Cancer Center and Capital Breast Care Center ... breast cancer screening to underserved women at the annual ... is the second year the AVON Foundation has recognized ... Care Center to their dedication to breast cancer prevention ...
... Bush Administration Proposal at Odds With Intent of Economic Stimulus, ... 1 Reaching back in time to propose implementing a ... seniors, Medicare funding by $1.05 billion in FY 2010 (estimated ... odds with the intent of the American Recovery and ...
... with cancer that is resistant to standard therapy is the ... obtained in some settings, in many cases the therapies have ... has now been uncovered by a team of researchers, led ... London School of Medicine and Dentistry, London. , In the ...
... Horizons Family Solutions LLC , the world,s leading provider ... and work/life solutions, today announced a new emergency or ... families manage during times of public health emergencies, like ... schools are closed and regular child care is not ...
Cached Medicine News:Health News:Twin Sisters Set Their Sights On Biathlon Gold At The 2010 Winter Games 2Health News:Lombardi Cancer Center and the Capital Breast Care Center awarded $750,000 from the AVON Foundation 2Health News:AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency 2Health News:AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency 3Health News:Bright Horizons Responds to National Health Emergency With Pandemic Alert Back-Up Child Care Solutions 2Health News:Bright Horizons Responds to National Health Emergency With Pandemic Alert Back-Up Child Care Solutions 3
...
...
...
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Shaft angled 45 degrees. Manufactured in titanium....
Medicine Products: